Oscar Health Inc expected to post a loss of 46 cents a share - Earnings Preview

Oscar Health

04/08/2025 14:41

Oscar Health Inc OSCR.N, OSCR.K is expected to  show a rise in quarterly revenue when it reports  results on August 6 for the period ending June 30 2025

The New York City-based  company is expected to report a 30.3% increase in revenue to $2.891 billion from $2.22 billion a year ago, according to the mean estimate from 7 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Oscar Health Inc is for a loss of 46 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 4 "hold" and 5 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Oscar Health Inc is $11.00, about 23.5% below its last closing price of $13.58

The company's guidance on July 22 2025 for the period ended June 30 was for Earnings before Interest and Taxes of USD-230 million.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.79
0.79
0.92
Beat
16.1
Dec. 31 2025
-0.59
-0.59
-0.62
Missed
-5.1
Sep. 30 2024
-0.18
-0.17
-0.22
Missed
-28.3​
Jun. 30 2024
0.17
0.16
0.20
Beat
23.7
​​Mar. 31 2024
0.27
0.27
0.62
Beat
127.9
Dec. 31 2023
-0.73
-0.72
-0.66
Beat
8.7​
Sep. 30 2023
-0.47
-0.47
-0.29
Beat
38.6
Jun. 30 2023
-0.22
-0.23
-0.07
Beat
69.6

This summary was machine generated August 4 at 13:41 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)